The Global Clinical Trial Services Market size is valued at USD 22.58 billion in 2023 and is predicted to reach USD 42.86 billion by the year 2031 at an 8.44% CAGR during the forecast period for 2024-2031.
The services used by biopharmaceutical or pharmaceutical companies to conduct clinical trial either for the approval of a new drug or biologic or for the entry of new generic or biosimilar to the market is known as clinical trial services. Increased research and development expenditure and entry of biosimilars to the market has boosted the growth of the clinical trial services market. Major companies have increased research and development expenditure to bring new molecules to the market in order to beat the market competition and to sustain the market position. A significant part of the research and development expenditure of pharmaceutical and biopharmaceutical companies goes on clinical trials, thus growing demand for new drug development and increase in a number of contract research organizations have boosted the growth of the global clinical trial services market. However, the stringent regulatory framework hampers the growth of the global clinical trials services market in the forecast period. Additionally, the lack of skilled professionals to conduct clinical trials also restrains the development of the global clinical trial services market.
The Clinical Trial Services Market is segmented by service, by phase, by sponsor Outlook. Based on By Service Outlook, the market is segmented into clinical trial site management, patient recruitment management, (patient recruitment & registry services, patient retention, others), data management, administrative staff, IRB, others. By Phase the market is segmented into Phase I, Phase II, Phase III and Phase IV. By Sponsor, the market segmented into pharmaceutical & biopharmaceutical, medical devices, others.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 22.58 Bn |
| Revenue Forecast in 2031 | USD 42.86 Bn |
| Growth Rate CAGR | CAGR of 8.0 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Service, By Phase, By Sponsor |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Covance, Inc., Charles River Laboratories, Acura Health, Parexel International, Accovion GmbH, ICON PLC, Chiltern International Limited, inVentiv International Pharma Services, Pharmaceutical Product Development LLC, Pharmnet, IQVIA, Quotient Bioresearch, WuXi PharmaTech, and others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trial Services Market Snapshot
Chapter 4. Global Clinical Trial Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Outlook Estimates & Trend Analysis
5.1. By Service Outlook & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Service Outlook:
5.2.1. Clinical Trial Site Management
5.2.2. Patient Recruitment Management
5.2.2.1. Patient recruitment & registry services
5.2.2.2. Patient retention
5.2.2.3. Others
5.2.6. Data Management
5.2.7. Administrative staff
5.2.8. IRB
5.2.9. Others
Chapter 6. Market Segmentation 2: By Phase Estimates & Trend Analysis
6.1. By Phase & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Phase:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Market Segmentation 3: By Sponsor Estimates & Trend Analysis
7.1. By Sponsor & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Sponsor:
7.2.1. Pharmaceutical & Biopharmaceutical
7.2.2. Medical Devices
7.2.3. Others
Chapter 8. Clinical Trial Services Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.1.2. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.1.3. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.1.4. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.2. Europe
8.2.1. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.2.2. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.2.3. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.2.4. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.3.2. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.3.3. Asia-Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.3.4. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.4. Latin America
8.4.1. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.4.2. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.4.3. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.4.4. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.5.2. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.5.3. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.5.4. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. PharmaLex
9.2.2. Emergo UL
9.2.3. Cytel
9.2.4. Health Policy Associate
9.2.5. CD BioSciences
9.2.6. LLX Solutions
9.2.7. SGS
9.2.8. ADM Korea
9.2.9. ClinAsia
9.2.10. BioPoint
9.2.11. Covance, Inc
9.2.12. Charles River Laboratories
9.2.13. Alcura Health
9.2.14. Parexel International
9.2.15. Accovion GmbH
9.2.16. ICON PLC
9.2.17. Chiltern International Limited
9.2.18. inVentiv International Pharma Services
9.2.19. Pharmaceutical Product Development LLC
9.2.20. Pharmnet
9.2.21. IQVIA
9.2.22. Syneos Health
9.2.23. Quotient Bioresearch
9.2.24. WuXi PharmaTech
9.2.25. Other Prominent Players
Clinical Trial Services Market- By Service
Clinical Trial Services Market- Distribution by Phase
Clinical Trial Services Market- By Sponsor
Global Clinical Trial Services Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region